0001615219-24-000015.txt : 20240222 0001615219-24-000015.hdr.sgml : 20240222 20240222163710 ACCESSION NUMBER: 0001615219-24-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosenblum Mark J CENTRAL INDEX KEY: 0001329154 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 24665483 MAIL ADDRESS: STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218 CITY: DALLAS STATE: TX ZIP: 75244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wk-form4_1708637819.xml FORM 4 X0508 4 2024-02-20 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001329154 Rosenblum Mark J C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOMBE BLVD., SUITE X HOUSTON TX 77021 0 1 0 0 Exec VP Finance, CFO 0 Stock Option (right to buy) 0.5711 2024-02-20 4 A 0 22500 0 A 2025-02-20 2034-02-19 Common Stock 22500 22500 D 25% of the options are vested on February 20, 2025, and 1/36 of the remaining options vest on each monthly anniversary thereafter for 36 months. /s/ Mark J. Rosenblum 2024-02-22